Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Innovation Limited
Symbol
CNTB
Shares outstanding
55,813,953 shares
Disclosed Ownership
12,000,000 shares
Ownership
22%
Form type
SCHEDULE 13D/A
Filing time
26 Nov 2025, 16:30:02 UTC
Date of event
24 Nov 2025
Next filing
01 Apr 2026

Sponsored

Quoteable Key Fact

"Panacea Innovation Ltd disclosed 22% ownership in Connect Biopharma Holdings Limited Ordinary Shares (CNTB) on 24 Nov 2025."

Quick Takeaways

  • Panacea Innovation Ltd filed SCHEDULE 13D/A for Connect Biopharma Holdings Limited Ordinary Shares (CNTB).
  • Disclosed ownership: 22%.
  • Date of event: 24 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 26 Nov 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Innovation Limited 22% 12,000,000 0 12,000,000 /s/ James Huang James Huang, Founding Managing Partner 0002010692
Panacea Venture Healthcare Fund II, L.P. 22% 12,000,000 0 12,000,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner 0001869939
Panacea Venture Healthcare Fund II GP Company, Ltd. 22% 12,000,000 0 12,000,000 /s/ James Huang James Huang, Founding Managing Partner
James Huang 22% 12,000,000 0 12,000,000 /s/ James Huang James Huang 0001573160